newsfilter
← Latest News
GlobeNewswire·

Kymera Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026

WATERTOWN, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ:KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological